FDA Orders New GLP-1 Risk Warnings Over Vision Loss
The U.S. Food and Drug Administration on Monday said it is requiring new warnings on GLP-1 medications, the group of blockbuster drugs prescribed for diabetes and weight loss, for a serious,...To view the full article, register now.
Already a subscriber? Click here to view full article